These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

643 related items for PubMed ID: 26305793

  • 1. Evaluating the A-Subunit of the Heat-Labile Toxin (LT) As an Immunogen and a Protective Antigen Against Enterotoxigenic Escherichia coli (ETEC).
    Norton EB, Branco LM, Clements JD.
    PLoS One; 2015; 10(8):e0136302. PubMed ID: 26305793
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Toxicity and immunogenicity of Enterotoxigenic Escherichia coli heat-labile and heat-stable toxoid fusion 3xSTa(A14Q)-LT(S63K/R192G/L211A) in a murine model.
    Zhang C, Knudsen DE, Liu M, Robertson DC, Zhang W, STa Toxoid Vaccine Consortium Group.
    PLoS One; 2013; 8(10):e77386. PubMed ID: 24146989
    [Abstract] [Full Text] [Related]

  • 4. A tripartite fusion, FaeG-FedF-LT(192)A2:B, of enterotoxigenic Escherichia coli (ETEC) elicits antibodies that neutralize cholera toxin, inhibit adherence of K88 (F4) and F18 fimbriae, and protect pigs against K88ac/heat-labile toxin infection.
    Ruan X, Liu M, Casey TA, Zhang W.
    Clin Vaccine Immunol; 2011 Oct; 18(10):1593-9. PubMed ID: 21813665
    [Abstract] [Full Text] [Related]

  • 5. Escherichia coli K88ac fimbriae expressing heat-labile and heat-stable (STa) toxin epitopes elicit antibodies that neutralize cholera toxin and STa toxin and inhibit adherence of K88ac fimbrial E. coli.
    Zhang C, Zhang W.
    Clin Vaccine Immunol; 2010 Dec; 17(12):1859-67. PubMed ID: 20980482
    [Abstract] [Full Text] [Related]

  • 6. Immunogenicity of a fusion protein comprising coli surface antigen 3 and labile B subunit of enterotoxigenic Escherichia coli.
    Alerasol M, Mousavi Gargari SL, Nazarian S, Bagheri S.
    Iran Biomed J; 2014 Dec; 18(4):212-218. PubMed ID: 25326019
    [Abstract] [Full Text] [Related]

  • 7. Attenuated Escherichia coli strains expressing the colonization factor antigen I (CFA/I) and a detoxified heat-labile enterotoxin (LThK63) enhance clearance of ETEC from the lungs of mice and protect mice from intestinal ETEC colonization and LT-induced fluid accumulation.
    Byrd W, Boedeker EC.
    Vet Immunol Immunopathol; 2013 Mar 15; 152(1-2):57-67. PubMed ID: 23122616
    [Abstract] [Full Text] [Related]

  • 8. Preclinical Characterization of Immunogenicity and Efficacy against Diarrhea from MecVax, a Multivalent Enterotoxigenic E. coli Vaccine Candidate.
    Seo H, Garcia C, Ruan X, Duan Q, Sack DA, Zhang W.
    Infect Immun; 2021 Jun 16; 89(7):e0010621. PubMed ID: 33875477
    [Abstract] [Full Text] [Related]

  • 9. Heat-labile- and heat-stable-toxoid fusions (LTR₁₉₂G-STaP₁₃F) of human enterotoxigenic Escherichia coli elicit neutralizing antitoxin antibodies.
    Liu M, Ruan X, Zhang C, Lawson SR, Knudsen DE, Nataro JP, Robertson DC, Zhang W.
    Infect Immun; 2011 Oct 16; 79(10):4002-9. PubMed ID: 21788385
    [Abstract] [Full Text] [Related]

  • 10. Neutralizing Anti-Heat-Stable Toxin (STa) Antibodies Derived from Enterotoxigenic Escherichia coli Toxoid Fusions with STa Proteins Containing N12S, L9A/N12S, or N12S/A14T Mutations Show Little Cross-Reactivity with Guanylin or Uroguanylin.
    Duan Q, Huang J, Xiao N, Seo H, Zhang W.
    Appl Environ Microbiol; 2018 Jan 15; 84(2):. PubMed ID: 29079628
    [Abstract] [Full Text] [Related]

  • 11. Development and preclinical evaluation of safety and immunogenicity of an oral ETEC vaccine containing inactivated E. coli bacteria overexpressing colonization factors CFA/I, CS3, CS5 and CS6 combined with a hybrid LT/CT B subunit antigen, administered alone and together with dmLT adjuvant.
    Holmgren J, Bourgeois L, Carlin N, Clements J, Gustafsson B, Lundgren A, Nygren E, Tobias J, Walker R, Svennerholm AM.
    Vaccine; 2013 May 07; 31(20):2457-64. PubMed ID: 23541621
    [Abstract] [Full Text] [Related]

  • 12. Genetic fusions of heat-labile (LT) and heat-stable (ST) toxoids of porcine enterotoxigenic Escherichia coli elicit neutralizing anti-LT and anti-STa antibodies.
    Zhang W, Zhang C, Francis DH, Fang Y, Knudsen D, Nataro JP, Robertson DC.
    Infect Immun; 2010 Jan 07; 78(1):316-25. PubMed ID: 19858307
    [Abstract] [Full Text] [Related]

  • 13. Genetic fusions of heat-labile toxoid (LT) and heat-stable toxin b (STb) of porcine enterotoxigenic Escherichia coli elicit protective anti-LT and anti-STb antibodies.
    Zhang W, Francis DH.
    Clin Vaccine Immunol; 2010 Aug 07; 17(8):1223-31. PubMed ID: 20505006
    [Abstract] [Full Text] [Related]

  • 14. Immunizations with Enterotoxigenic Escherichia coli Heat-Stable Toxin Conjugates Engender Toxin-Neutralizing Antibodies in Mice That Also Cross-React with Guanylin and Uroguanylin.
    Diaz Y, Govasli ML, Zegeye ED, Sommerfelt H, Steinsland H, Puntervoll P.
    Infect Immun; 2019 Jul 07; 87(7):. PubMed ID: 31061144
    [Abstract] [Full Text] [Related]

  • 15. Protection of mice against enterotoxigenic E. coli by immunization with a polyvalent enterotoxin comprising a combination of LTB, STa, and STb.
    You J, Xu Y, He M, McAllister TA, Thacker PA, Li X, Wang T, Jin L.
    Appl Microbiol Biotechnol; 2011 Mar 07; 89(6):1885-93. PubMed ID: 21085949
    [Abstract] [Full Text] [Related]

  • 16. Antibodies derived from a toxoid MEFA (multiepitope fusion antigen) show neutralizing activities against heat-labile toxin (LT), heat-stable toxins (STa, STb), and Shiga toxin 2e (Stx2e) of porcine enterotoxigenic Escherichia coli (ETEC).
    Rausch D, Ruan X, Nandre R, Duan Q, Hashish E, Casey TA, Zhang W.
    Vet Microbiol; 2017 Apr 07; 202():79-89. PubMed ID: 26878972
    [Abstract] [Full Text] [Related]

  • 17. Analysis and application of a neutralizing linear epitope on liable toxin B of enterotoxin Escherichia coli.
    Guan W, Liu W, Bao J, Li J, Yuan C, Tang J, Shi D.
    Appl Microbiol Biotechnol; 2015 Jul 07; 99(14):5985-96. PubMed ID: 25794873
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.